1 | Extended-release oxycodone | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬 |
2 | Oxycodone | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 6 6, 13, 70, 226, 298 💬 |
3 | Oxycodone Depot ”Sandoz”, depot tablets | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 298 298 💬 |
4 | OXYCODONE HYDROCHLORIDE | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 6 6, 70, 226, 298 💬 |
5 | Oxycodone naloxone prolonged release tablets | [2] Naloxone Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
6 | Oxycodone Orion | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬 |
7 | Oxycodone/naloxone prolonged release t | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
8 | Oxycodone/Naloxone Prolonged Release tablets | [2] Naloxone Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
9 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
10 | Oxycodone/naloxone prolonged release tablets 10/5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
11 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
12 | Oxycodone/naloxone prolonged release tablets 20/10 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
13 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
14 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬 |
15 | PR Oxycodone | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬 | [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |